Clinical Trials Browser

Phase 1 × Lymphoma, B-Cell × Biological Products × Clear all

NCT03383952 2017-12-27

A Clinical Study of CD19 Targeted CAR-T for Patients With CD19+ Lymphoma and Leukemia

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell